Loss of Smad3 modulates wound healing

Cytokine and Growth Factor Reviews

Volumn 11, Issue 1-2, 2000, Pages 125-131

  Ashcroft, Gillian S ^a   Roberts, Anita B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Inflammation; SMAD; TGF signaling; Wound healing

Indexed keywords

DNA BINDING PROTEIN; PROTEIN SMAD3; SMAD PROTEIN; SMAD2 PROTEIN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; CELL FUNCTION; DRUG EFFECT; EPITHELIZATION; GENETICS; HUMAN; INFLAMMATION; KERATINOCYTE; METABOLISM; MOUSE; PHYSIOLOGY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR; WOUND HEALING;

ANIMALS; DNA-BINDING PROTEINS; HUMANS; KERATINOCYTES; MICE; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

ANIMALIA;

EID: 0034108424     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(99)00036-2     Document Type: Review

References (52)

1. Singer A.J., Clark R.A. Cutaneous wound healing. N. Engl. J. Med. 341:1999;738-746.
2. Roberts A.B. Transforming growth factor-beta: activity and efficacy in animal models of wound healing. Wound Repair and Regeneration. 3:1995;408-418.
3. Roberts A.B., Sporn M.B. Transforming growth factor-β Clark R.A.F., The molecular and cellular biology of wound repair. 1996;275-308 Plenum Press, New York.
4. Grainger D.J., Wakefield L., Bethell H.W., Farndale R.W., Metcalfe J.C. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat. Med. 1:1995;932-937.
5. Roberts A.B., Sporn M.B. The transforming growth factors-β Sporn M.B., Roberts A.B., Handbook of experimental pharmacology. Peptide growth factors and their receptors. 1990;419-472 Springer-Verlag, New York.
6. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M., Heine U.I., Liotta L.A., Falanga V., Kehrl J.H., Fauci A.S. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA. 83:1986;4167-4171.
7. Beck L.S., Chen T.L., Hirabayashi S.E., DeGuzman L., Lee W.P., McFatridge L.L., et al. Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor-beta 1. Growth Factors. 2:1990;273-282.
8. Beck L.S., DeGuzman L., Lee W.P., Xu Y., Siegel M.W., Amento E.P. One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing. J. Clin. Invest. 92:1993;2841-2849.
9. Mustoe T.A., Pierce G.F., Thomason A., Gramates P., Sporn M.B., Deuel T.F. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science. 237:1987;1333-1336.
10. Robson M.C., Phillips L.G., Cooper D.M., Robson L.E., Hanham A.F., Ksander G.A. Transforming growth factor-β2 accelerates healing of venous stasis ulcers in an open-label, placebo controlled clinical study. Wound Rep. Reg. 3:1995;157-167.
11. Quaglino D. Jr, Nanney L.B., Kennedy R., Davidson J.M. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model. Lab. Invest. 63:1990;307-319.
12. Hebda P.A. Stimulatory effects of transforming growth factor-beta and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. J. Invest. Dermatol. 91:1988;440-445.
13. Zhang Y., Derynck R. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends. Cell Biol. 9:1999;274-279.
14. Massagué J. TGF-beta signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
15. Hartsough M.T., Mulder K.M. Transforming growth factor-beta signaling in epithelial cells. Pharmacol. Ther. 75:1997;21-41.
16. Derynck R., Zhang Y., Feng X.H. Smads: transcriptional activators of TGF-beta responses. Cell. 95:1998;737-740.
17. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16:1997;5353-5362.
18. Yagi K., Goto D., Hamamoto T., Takenoshita S., Kato M., Miyazono K. Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274:1999;703-709.
19. Kurokawa M., Mitani K., Irie K., Matsuyama T., Takahashi T., Chiba S., et al. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature. 394:1998;92-96.
20. Kurokawa M., Mitani K., Imai Y., Ogawa S., Yazaki Y., Hirai H. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells. Blood. 92:1998;4003-4012.
21. Stroschein S.L., Wang W., Zhou S., Zhou Q., Luo K. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science. 286:1999;771-774.
22. Luo K., Stroschein S.L., Wang W., Chen D., Martens E., Zhou S., Zhou Q. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev. 13:1999;2196-2206.
23. Yanagi Y., Suzawa M., Kawabata M., Miyazono K., Yanagisawa J., Kato S. Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through Smad proteins. J. Biol. Chem. 274:1999;12971-12974.
24. Song C.Z., Tian X., Gelehrter T.D. Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. Proc. Natl. Acad. Sci. USA. 96:1999;11,776-11,781.
25. Nomura M., Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature. 393:1998;786-790.
26. Weinstein M., Yang X., Li C., Xu X., Gotay J., Deng C.X. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor Smad2. Proc. Natl. Acad. Sci. USA. 98:1998;9378-9383.
27. Waldrip W.R., Bikoff E.K., Hoodless P.A., Wrana J.L., Robertson E.J. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell. 92:1998;797-808.
28. Datto M.B., Frederick J.P., Pan L., Borton A.J., Zhuang Y., Wang X.F. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol.Cell Biol. 19:1999;2495-2504.
29. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., et al. Targeted disruption of Smad3 results in impaired mucosal immunity and diminished T-cell responsiveness to TGF-beta. EMBO J. 18:1999;1280-1291.
30. Zhu Y., Richardson J.A., Parada L.F., Graff J.M. Smad3 mutant mice develop metastatic colorectal cancer. Cell. 94:1998;703-714.
31. Ashcroft G.S., Yang X., Glick A., Weinstein M., Letterio J.J., Mizel D.E., et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nature Cell Biol. 1:1999;260-266.
32. Gross J., Farinelli W., Sadow P., Anderson R., Bruns R. On the mechanism of skin wound "contraction": a granulation tissue "knockout" with a normal phenotype. Proc. Natl. Acad. Sci. USA. 92:1995;5982-5986.
33. Wahl S.M., Costa G.L., Mizel D.E., Allen J.B., Skaleric U., Mangan D.F. Role of transforming growth factor beta in the pathophysiology of chronic inflammation. J. Periodontol. 64:1993;450-455.
34. Wahl S.M., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B., Sporn M.B. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA. 84:1987;5788-5792.
35. Hocevar B.A., Brown T.L., Howe P.H. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18:1999;1345-1356.
36. Chen S.J., Yuan W., Mori Y., Levenson A., Trojanowska M., Varga J. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J. Invest. Dermatol. 112:1999;49-57.
37. Vindevoghel L., Lechleider R.J., Kon A., de Caestecker M.P., Uitto J., Roberts A.B., Mauviel A. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc. Natl. Acad. Sci. USA. 95:1998;14,769-14,774.
38. Kretzschmar M., Doody J., Massagué J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature. 389:1997;618-622.
39. Kretzschmar M., Doody J., Timokhina I., Massagué J. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev. 13:1999;804-816.
40. Ulloa L., Doody J., Massagué J. Inhibition of transforming growth factor-beta/Smad signalling by the interferon-gamma/STAT pathway. Nature. 397:1999;710-713.
41. de Caestecker M.P., Parks W.T., Frank C.J., Castagnino P., Bottaro D.P., Roberts A.B., Lechleider R.J. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev. 12:1998;1587-1592.
42. Sano Y., Harada J., Tashiro S., Gotoh-Mandeville R., Maekawa T., Ishii S. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling. J. Biol. Chem. 274:1999;8949-8957.
43. Nakashima K., Yanagisawa M., Arakawa H., Kimura N., Hisatsune T., Kawabata M., et al. Synergistic signaling in fetal brain by STAT3-smad1 complex bridged by p300. Science. 284:1999;479-482.
44. Yanagisawa K., Osada H., Masuda A., Kondo M., Saito T., Yatabe Y., et al. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells. Oncogene. 17:1998;1743-1747.
45. Ashcroft G.S., Horan M.A., Ferguson M.W. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab. Invest. 78:1998;47-58.
46. Ashcroft G.S., Horan M.A., Herrick S.E., Tarnuzzer R.W., Schultz G.S., Ferguson M.W. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res. 290:1997;581-591.
47. Ashcroft G.S., Herrick S.E., Tarnuzzer R.W., Horan M.A., Schultz G.S., Ferguson M.W. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J. Pathol. 183:1997;169-176.
48. Ashcroft G.S., Kielty C.M., Horan M.A., Ferguson M.W. Age-related changes in the temporal and spatial distributions of fibrillin and elastin mRNAs and proteins in acute cutaneous wounds of healthy humans. J. Pathol. 183:1997;80-89.
49. Goto D., Yagi K., Inoue H., Iwamoto I., Kawabata M., Miyazono K., Kato M. A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-beta signals. FEBS Lett. 430:1998;201-204.
50. Lange D., Persson U., Wollina U., ten Dijke P., Castelli E., Heldin C.H., Funa K. Expression of TGF-beta related Smad proteins in human epithelial skin tumors. Int. J. Oncol. 14:1999;1049-1056.
51. Khalil N., Bereznay O., Sporn M., Greenberg A.H. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:1989;727-737.
52. Border W.A., Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J. Clin. Invest. 90:1992;1-7.